Heart Attack
A heart attack, or ST-segment myocardial infarction (STEMI), occurs when blood flow to a part of the heart is blocked, causing damage to the heart muscle. This can lead to severe chest pain and other symptoms.
We are investigating whether a steroid given before hospital treatment can reduce heart damage in patients with a heart attack. This study aims to improve heart function and decrease inflammation after the event.
Health conditions and diseases that the clinical trial is designed to study and treat.
A heart attack, or ST-segment myocardial infarction (STEMI), occurs when blood flow to a part of the heart is blocked, causing damage to the heart muscle. This can lead to severe chest pain and other symptoms.
These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..
Medicines that are officially approved for use in the European Union and considered safe by EMA. These medicines are already on the market and may be tested for new conditions or populations.
Active substances that are officially approved for use in the European Union and considered safe by EMA. These substances are already on the market and may be tested for new conditions or populations.
Don't worry if you don't know the medicines tested in the trial. There is a chance you have heard about the similar medicines. Check the list below to see if you are familiar with any of them.
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.